You can buy or sell Amarin and other stocks, options, ETFs, and crypto commission-free!
Amarin Corporation plc, also called Amarin, is a biopharmaceutical company, which focuses on the commercialization and development of therapeutics for cardiovascular health. Its product development program leverages its experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids. Read More It has developed and markets Vascepa capsules through wholesale. The company was founded by Geoffrey W. Guy on March 1, 1989 and is headquartered in Dublin, Ireland.
52 Week High
52 Week Low
Amarin Analysts React To Vascepa Patent Loss, See Small Chance Of Overturning Judgment
Amarin Corporation plc (NASDAQ: AMRN) shares were tumbling Tuesday in reaction to a negative verdict issued by a U.S. District Court regarding generic versions
Amarin's stock plummets on heavy volume after court rules in favor of makers of generic Vascepa
Shares of Amarin Corp. PLC AMRN, +2.57% took a 69% dive on heavy volume in premarket trading Tuesday, after drug maker announced a disappointing court ruling in
— per share
Expected Apr 29, After Hours